Structure Therapeutics Inc Sustainability Reports
A clinical-stage biopharmaceutical company developing oral small molecule therapeutics for chronic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG01CBVHMQ6
2 reports from 2023 to 2024